Cerebral toxoplasmosis after rituximab for pemphigus vulgaris

Erica B Lee; Noura Ayoubi; Mehmet Albayram; Vidhu Kariyawasam; Kiran Motaparthi

doi:10.1016/j.jdcr.2019.10.015

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris

JAAD Case Rep. 2019 Dec 24;6(1):37-41. doi: 10.1016/j.jdcr.2019.10.015. eCollection 2020 Jan.

Authors

Erica B Lee¹, Noura Ayoubi², Mehmet Albayram³, Vidhu Kariyawasam⁴, Kiran Motaparthi⁵

Affiliations

¹ Department of Medicine, Santa Barbara Cottage Hospital, Santa Barbara, California.
² Morsani College of Medicine, University of South Florida, Tampa, Florida.
³ Department of Radiology, University of Florida College of Medicine, Gainesville, Florida.
⁴ Division of Infectious Diseases & Global Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida.
⁵ Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida.

No abstract available

Keywords: CNS, central nervous system; CSF, cerebrospinal fluid; Cerebral toxoplasmosis; MMF, mycophenolate mofetil; MRI, magnetic resonance imaging; PML, progressive multifocal leukoencephalopathy; PV, pemphigus vulgaris; TMP-SMX, trimethoprim-sulfamethoxazole; pemphigus vulgaris; progressive multifocal leukoencephalopathy; rituximab.

Publication types

Case Reports